نتایج جستجو برای: لیزر arf

تعداد نتایج: 7134  

2013
Kapil Kapoor Mamta Jajoo Vikas Dabas

OBJECTIVE To evaluate the incidence, etiology, outcome, and predictors of mortality in neonates with Acute Renal Failure (ARF) in an out born Neonatal Intensive Care Unit (NICU) of India. METHODS A retrospective analysis of case records of out born neonates, who had ARF at admission or developed ARF during NICU stay, from January to December 2011 (one year) was done. FINDINGS Out of the tot...

Journal: :Cancer research 2002
Wendell G Yarbrough Mika Bessho Adam Zanation John E Bisi Yue Xiong

Using alternative reading frames, the human ARF-INK4a locus encodes two unrelated proteins that both function in tumor suppression. p16(INK4a) maintains the retinoblastoma protein in its growth-suppressive state through inhibition of cyclin D-dependent kinase activity, whereas ARF binds with MDM2 and stabilizes p53. The majority of the activity of ARF to date is ascribed to its ability to activ...

Journal: :Cancer research 2001
C T Yang L You K Uematsu C C Yeh F McCormick D M Jablons

ONYX-015 has been reported to kill selectively tumor cells lacking functional p53. Genetic alterations of INK4a/ARF locus, which is a predominant event in malignant pleural mesothelioma, may result in loss of p14(ARF) and subsequent disruption of p53 pathway in cancer cells. In the present study, ONYX-015 was able to kill three mesothelioma cell lines (H28, H513, and 211H) with wild-type p53 bu...

Journal: :Cancer research 2010
Hiroyuki Kawagishi Hideaki Nakamura Mitsuo Maruyama Shuki Mizutani Kazushi Sugimoto Masatoshi Takagi Masataka Sugimoto

Vascular endothelial growth factor A (VEGFA) is a specific mitogen for vascular endothelial cells that plays a critical role in cancer neoangiogenesis. Here, we report that the nucleolar tumor suppressor p19(ARF) suppresses VEGFA expression, acting at the level of mRNA translation without affecting the transcription of the VEGFA gene. Translational repression of VEGFA mRNA by p19(ARF) does not ...

2004
MS Amaresan

255 Acute Renal Failure (ARF) is a common and a potentially devastating disorder with a higher prevalence in the intensive care units. ARF occurs in 10 to 15% of critically ill patients with a mortality of 78 to 90%.1 The estimates can differ due to the lack of consensus on the definition of ARF itself. They can prove conservative in the face of the aging population with increased comorbidities...

2012
Yi-Ping Chang San-Kuei Huang Ping Tao Ching-Wen Chien

BACKGROUND Because of the rapid growth in elderly population, polypharmacy has become a serious public health issue worldwide. Although acute renal failure (ARF) is one negative consequence of polypharmacy, the association between the duration of polypharmacy and ARF remains unclear. We therefore assessed this association using a population-based database. METHODS Data were collected from the...

Journal: :Pediatrics international : official journal of the Japan Pediatric Society 2011
Gülcan Türker Gamze Ozsoy Ayla Günlemez Ayşe S Gökalp Ayşe E Arisoy Zelal Bircan

BACKGROUND The aim of the present study was to determine, using the score for neonatal acute physiology and perinatal extension II (SNAPPE-II), whether there is an association with acute renal failure (ARF) and whether it is possible to identify newborns at risk for ARF prior to a rise in creatinine in newborns. METHODS Information on postnatal risk factors and SNAPPE-II on the first day of l...

2011
Yaxue Zeng Yojiro Kotake Xin-Hai Pei Matthew D. Smith Yue Xiong

The expression of tumor suppressor Arf is tightly repressed during normal cell growth at a young age and is activated by oncogenic insults, and during aging, results in p53 activation and cell-cycle arrest to prevent hyperproliferation. The mechanisms of both transcriptional repression and activation of Arf are not understood. We show that p53 binds to and represses Arf expression and that this...

Journal: :Cancer research 2003
Mark D'Amico Kongming Wu Dolores Di Vizio Anne T Reutens Mark Stahl Maofu Fu Chris Albanese Robert G Russell William J Muller Michael White Abdissa Negassa Han-Woong Lee Ronald A DePinho Richard G Pestell

Most human tumors display inactivation of the p53 and the p16(INK4)/pRb pathway. The Ink4a/alternative reading frame (ARF) locus encodes the p16(INK4a) and p14(ARF) (murine p19(ARF)) proteins. p16(INK4a) is deleted in 40-60% of breast cancer cell lines, and p16(INK4a) inactivation by DNA methylation occurs in < or =30% of human breast cancers. In mice genetically heterozygous for p16(INK4a) or ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2002
Robyn N McKeller Jennifer L Fowler Justine J Cunningham Nikita Warner Richard J Smeyne Frederique Zindy Stephen X Skapek

A key tumor suppressor mechanism that is disrupted frequently in human cancer involves the ARF and p53 genes. In mouse fibroblasts, the Arf gene product responds to abnormal mitogenic signals to activate p53 and trigger either cell cycle arrest or apoptosis. Recent evidence indicates that Arf also has p53-independent functions that may contribute to its tumor suppressor activity. Using Arf(-/-)...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید